Boehringer Ingelheim open new plant in Catalonia
Boehringer Ingelheim has opened a new manufacturing facility in the town of Sant Cugat del Vallès near Barcelona.
The new plant will manufacture Boehringer Ingelheim’s COPD and asthma drug Respimat.
The Catalonia facility has seen Boheringer invest €120 million into the new plant which will see the creation of up to 200 new jobs.
Peter Ploeger, Managing Director of Boehringer Ingelheim Spain, commented: “This new plant is a recognition of the excellence and professionalism of hundreds of workers who, through their dedication, efforts, and commitment, have positioned the Boehringer Ingelheim facilities in Sant Cugat as one of the Group’s European innovation hubs, and a global leader due to its excellence, quality and environmental standards.”
The 17,000 sqm facility will include production areas, laboratories, technical areas, warehouses and an office.
Eli Lilly and Boehringer Ingelheim have announced that the US Food and Drug Administration (FDA) …
The technological pharmaceutical company IMIDEX has been granted clearance from the US Food and Drug …